September 26, "Beijing to further reform and improve the implementation of the policy of drug production, circulation and use of the implementation of the program" was officially released, 23 new policy involves the approval of drugs, supply, procurement and distribution, drug price monitoring, pharmaceutical cost control. According to the "implementation program", outpatients can independently choose to purchase drugs in medical institutions or retail pharmacies, medical institutions shall not restrict outpatients with a prescription to retail pharmacies to purchase drugs; "implementation program" also proposed to develop a drug "double ticket system" of the rules for the end of this year to launch.
Too much money for drugs, too expensive to buy drugs, has been criticized by the patient's medical problems. It not only puts a heavy financial burden on patients, but also makes health insurance funds misappropriated and does not play its proper role. If we want to solve this problem, compressing the undue profits of the intermediate links is the work that must be done. Over the years, healthcare reforms have been implemented continuously, and many of the approaches to reform are targeted at the intermediate links, such as the tendering of pharmaceutical platforms, and then the push for affordable medicines and efforts to realize the separation of medicine. These measures have had some effect, but I'm afraid there is still a relatively large gap between them and the ideal state.
With the implementation of the "two-invoice system", patients can trace the source price of drugs to see if there is a "profiteering" by middlemen, and to see if the price of medicines is inflated, or whether it should have been this way in the first place. In the past, all the legendary private transactions, drug kickbacks and so on, will be exposed to the people's eyes. In other words, the implementation of the "two-ticket system" is likely to let the window open, let the sun shine in, making drug prices become more transparent, continue to compress the middleman's undue profit, the conscientious hospitals, conscientious drug companies are also more fair.
From another point of view, the "double-ticket system" on the production of drugs and the circulation of drugs, are a great constraint, if it can be implemented for a long time, the profits of the drugs in all aspects of the process, will be controlled in a reasonable, everyone can accept the scope of the system, which will change the endless pursuit of profits, and the pressure on society. This will also change the endless pursuit of profits by enterprises, which has put pressure on society. Drugs are a special commodity, this profit control, is necessary, need to control to change the mentality of operators.
In addition to upstream traceability, this "implementation program" also puts special emphasis on outpatients can independently choose where to buy drugs, including medical institutions and retail pharmacies. In fact, this is to give people an opportunity to "speak with their feet". Where the price is cheaper and more reasonable, outpatients can go where to buy drugs. This is a reform of the medicine terminal, which will stimulate healthy competition between medical institutions and retail pharmacies, and also control the profits of the terminal. Of course, this requires hardware upgrades, such as more retail pharmacies into the health insurance system, as well as price information networking, to provide patients with a choice of reference.